What Do We Know About Efficacy and Safety
Related Documents 2026 Summary of Major Modifications and Explanatory Notes (PDF, 123Ko) Active 2026 Monitoring Program (PDF, 91Ko) Active Archived 2023 Prohibited List (PDF, 681Ko) 2023 Summary of Major Modifications and Explanatory Notes (PDF, 147Ko) 2023 Monitoring Program (PDF, 96Ko) 2022 Prohibited List (PDF, 2.7Mo) 2022 Prohibited List - Explanatory notes (PDF, 117Ko) 2021 Prohibited List (PDF, 2.7Mo) 2020 Prohibited List (PDF, 240Ko) 2019 Prohibited List (PDF, 3.8Mo) 2018 Prohibited List (PDF, 257Ko) 2017 Prohibited List (PDF, 253Ko) 2016 Prohibited List (PDF, 255Ko) 2015 Prohibited List (PDF, 275Ko) Revised 2014 Prohibited List (PDF, 267Ko) Revised 2014 Prohibited List - Explanatory Note (PDF, 149Ko) 2014 Prohibited List (PDF, 267Ko) 2013 Prohibited List (PDF, 110Ko) 2012 Prohibited List (PDF, 110Ko) 2011 Prohibited List (PDF, 106Ko) 2010 Prohibited List (PDF, 91Ko) 2010 Additional Information on Pseudoephedrine (PDF, 36Ko) 2009 Prohibited List (PDF, 173Ko) 2008 Prohibited List (PDF, 146Ko) 2007 Prohibited List (PDF, 99Ko) 2006 Prohibited List (PDF, 98Ko) 2005 Prohibited List (PDF, 73Ko) 2004 Prohibited List (PDF, 62Ko) 2024 Prohibited List (PDF, 371Ko) Athlete and Athlete Support Personnel Guide to the 2024 Prohibited List (PDF, 1.3Mo) 2024 Summary of Major Modifications and Explanatory Notes (PDF, 135Ko) 2024 Monitoring Program (PDF, 92Ko) 2025 Prohibited List (PDF, 373Ko) 2025 Summary of Major Modifications and Explanatory Notes (PDF, 108Ko) 2025 Monitoring Program (PDF, 92Ko) Athlete and Athlete Support Personnel Guide to the 2025 Prohibited List (PDF, 2.9Mo) (PDF, 1.3Mo) 2024 Prohibited List (Arabic) (PDF, 2.8Mo) 2025 Prohibited List (Arabic) (PDF, 13.1Mo) Llista de prohibicions 2022 (PDF, 2.7Mo) Llista de prohibicions 2023 (PDF, 3.1Mo) 2024 Prohibited List (Catalan) (PDF, 1.3Mo) 2025 Prohibited List (Catalan) (PDF, 1.2Mo) Liste des interdictions 2023 (PDF, 701Ko) Rsum des principales modifications et notes explicatives 2023 (PDF, 160Ko) Programme de surveillance 2023 (PDF, 85Ko) Liste des interdictions 2022 (PDF, 2.6Mo) Liste des interdictions 2022 - Notes explicatives (PDF, 107Ko) Liste des interdictions 2021 (PDF, 2.6Mo) Liste des interdictions 2020 (PDF, 261Ko) Liste des interdictions 2019 (PDF, 3.8Mo) Liste des interdictions 2018 (PDF, 257Ko) Liste des interdictions 2017 (PDF, 252Ko) Liste des interdictions 2016 (PDF, 254Ko) Liste des interdictions 2015 (PDF, 276Ko) Liste des interdictions 2014 rvise (PDF, 266Ko) Liste des interdictions 2014 rvise - Note explicative (PDF, 149Ko) Liste des interdictions 2014 (PDF, 108Ko) Liste des interdictions 2013 (PDF, 107Ko) Liste des interdictions 2012 (PDF, 106Ko) Liste des interdictions 2011 (PDF, 106Ko) Liste des interdictions 2010 (PDF, 187Ko) Information supplmentaire sur la pseudophdrine 2010 (PDF, 36Ko) Liste des interdictions 2009 (PDF, 195Ko) Liste des interdictions 2008 (PDF, 158Ko) Liste des interdictions 2007 (PDF, 97Ko) Liste des interdictions 2006 (PDF, 94Ko) Liste des interdictions 2005 (PDF, 71Ko) Liste des interdictions 2004 (PDF, 65Ko) Liste des interdictions 2024 (PDF, 394Ko) Rsum des principales modifications et notes explicatives 2024 (PDF, 142Ko) Programme de surveillance 2024 (PDF, 84Ko) Liste des interdictions 2025 (PDF, 397Ko) Rsum des principales modifications et notes explicatives 2025 (PDF, 111Ko) Programme de surveillance 2025 (PDF, 85Ko) Guide pour les sportifs et leur personnel de soutien pour la Liste des interdictions 2025 (PDF, 2.9Mo) Verbotsliste 2022 (PDF, 400Ko) Verbotsliste 2023 (PDF, 411Ko) 2024 Prohibited List (German) (PDF, 268Ko) 2025 Prohibited List (German) (PDF, 360Ko) 2022 (PDF, 883Ko) 2023 (PDF, 954Ko) 2023 - (PDF, 332Ko) 2024 Prohibited List (Greek) (PDF, 929Ko) 2025 Prohibited List (Greek) (PDF, 1.2Mo) 2022 AIZLIEGTO VIELU UN METOU SARAKSTS (PDF, 477Ko) Aizliegto vielu un metou saraksts 2023
It is FDA-approved for several conditions, including pediatric growth hormone deficiency, adult growth hormone deficiency, Turner syndrome, idiopathic short stature, AIDS-associated wasting, and short bowel syndrome, and is sold under brand names including Genotropin, Humatrope, Norditropin, Saizen, and Omnitrope
South Lyon regenerative PRP therapy specialists at Rojas Regenerative Institute treat knee instability, ligament pain, limited mobility, swelling, stiffness, and mcl tear recovery using PRP in South Lyon and surrounding Oakland County areas
If you experience constipation, our guide on treating semaglutide-related constipation provides practical management strategies
.png)
